Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma

Clinical trial NCT00424515 · COMPLETED

Trial details

NCT number: NCT00424515
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mucosal Melanoma Acral/Lentiginous Melanoma Chronically Sun Damaged Melanomas

Start date: 2006-07-01
Primary completion: 2011-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.